Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Carisma Therapeutics ( (CARM) ) has issued an announcement.
Carisma Therapeutics Inc. has entered into a master services agreement with Danforth Global, Inc. and Danforth Advisors, LLC to receive finance and accounting services from Natalie McAndrew, who will serve as the interim Vice President of Finance and principal financial officer. This strategic appointment is expected to bolster the company’s financial management capabilities, enhancing its operational efficiency and potentially impacting its industry standing positively.
More about Carisma Therapeutics
YTD Price Performance: -86.38%
Average Trading Volume: 222,366
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $16.66M
See more insights into CARM stock on TipRanks’ Stock Analysis page.